METABOLIC LIVER DISEASE IN CHILDREN
Main Article Content
Abstract
Background: Metabolic liver disease in children is not similar that in adults, most of them are caused by genetic disoder. Most of symtoms of metabolic liver disease in children can present from childhood. In the case the diseases are not diagnosed and managed, they may progress to chronic liver disease in adults with consequences of cirrhosis, portal hypertension, end-stage liver disease or have acute episodes with the risk of death.... Up to now, we only have a few studies on metabolic liver disease in children. Aims: " Review of clinical and subclinical characteristics of metabolic liver diseases in children". Materials and methods: Descriptive study on group of metabolic liver disease patients at Vietnam National children’s hospital from 2008-2019. Results: There are 478 metabolic liver disease. NICCD group has highest rate with 186 cases (38.9%), average age 3,2 1,6 months with symtoms cholestasis, liver failure and Chubby face. 112 Wilson cases with an average age of 114.8 years, accounting for 23.4% of all group with many diverse phenotypes and progression. There are 64 patients (accounting for 13.5%) were diagnosed with Glycogenose by histopathological criteria, 38 Alagille patients (7.9%) who has not only cholestasis but also congenital heart disease, abnormal spine and kidney defects... PFIC syndrome has 14 cases (2.9%), 12 cases with ARC syndrome (2.5%), 3 cases anpha1antitrypsin deficiency(AAT) 0,6%. There were 49 cases (10.4%) included Rotor; bile acid metabolism disorder, Galactosemia, Tyrosinemia, DGOUK… (only 1 patient for each disease) and group of patients who have had abnormal liver test with evidence of a nonclassified metabolic disorder. Conclusion: Metabolic liver disease are complicated group, which can cause acute episode or chronic liver disease in children. Early detection and management of this group in th childhood not only cure patients but also limit the long-term consequences of the chronic liver disease in adulthood and genetic counseling
Article Details
Keywords
Metabolic liver disease, PFIC, Alagille, ARC, Wilson, Glycogenose
References
2. Khanna R, Alam S, Sherwani R, Arora S, Arora NK, Malik A. Alpha-1 antitrypsin deficiency among Indian children with liver disorders. Indian J Gastroenterol. 2006; vol 25 pages191–193
3. Zhang ZH, Lin WX, Deng M, et al. Clinical, molecular and func- tional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). PLoS One. 2014 vol 9 pages 89267
4. European Association for Study of Liver. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012 Vol 56 pages 671–685.
5. Arora NK, Arora S, Ahuja A, et al. Alpha 1 antitrypsin deficiency in children with chronic liver disease in North India. Indian Pediatr. 2010 vol 47, pages 1015–1023.
6. Keli Hansen, Simon Horslen et al. Metabolic liver disease in children (2008). Liver transplantation Vol 14, pages 713-733